David B Weiner Selected Research

vpr Gene Products

2/2010	Anti-cancer activity of the HIV accessory molecule viral protein R (Vpr): Delivery as a DNA expression plasmid or biologically active peptides.
3/2009	HIV-1 Vpr: regulator of viral survival.
1/2009	Anti-tumor activity mediated by protein and peptide transduction of HIV viral protein R (Vpr).
11/2006	Complete regression of established subcutaneous B16 murine melanoma tumors after delivery of an HIV-1 Vpr-expressing plasmid by in vivo electroporation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David B Weiner Research Topics

Disease

59	Infections 01/2022 - 10/2002
41	Neoplasms (Cancer) 03/2022 - 10/2002
20	Communicable Diseases (Infectious Diseases) 06/2020 - 01/2003
19	Human Influenza (Influenza) 08/2020 - 10/2003
10	COVID-19 12/2022 - 01/2020
10	HIV Infections (HIV Infection) 11/2021 - 12/2002
7	Inflammation (Inflammations) 01/2021 - 01/2002
7	Acquired Immunodeficiency Syndrome (AIDS) 01/2011 - 04/2004
6	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2021 - 05/2014
6	Virus Diseases (Viral Diseases) 01/2016 - 12/2008
5	Zika Virus Infection 01/2022 - 01/2016
5	Melanoma (Melanoma, Malignant) 11/2020 - 11/2006
4	Carcinoma (Carcinomatosis) 03/2022 - 02/2010
4	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 12/2017
4	Tuberculosis (Tuberculoses) 10/2016 - 01/2015
3	Reinfection 01/2022 - 01/2017
3	Dengue (Dengue Fever) 01/2022 - 10/2009
3	Uterine Cervical Dysplasia 01/2018 - 10/2012
3	Pneumonia (Pneumonitis) 01/2017 - 12/2005
3	Bacterial Infections (Bacterial Infection) 01/2017 - 07/2010
3	Viremia 02/2012 - 03/2005
3	Smallpox (Variola) 01/2011 - 05/2006
3	Vaccinia 01/2011 - 05/2006
3	Influenza in Birds (Avian Flu) 05/2009 - 04/2007
2	Fever (Fevers) 01/2021 - 01/2015
2	Malaria 01/2021 - 01/2020
2	Autoimmune Diseases (Autoimmune Disease) 09/2020 - 08/2014
2	Weight Loss (Weight Reduction) 04/2020 - 01/2016
2	Lyme Disease (Disease, Lyme) 01/2020 - 01/2019
2	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 01/2019
2	Rheumatoid Arthritis 03/2016 - 08/2014
2	Congenital Abnormalities (Deformity) 01/2015 - 11/2012
2	Hypoxia (Hypoxemia) 01/2015 - 03/2014
2	Disease Progression 06/2007 - 04/2004
1	Nasopharyngeal Carcinoma 03/2022
1	Squamous Intraepithelial Lesions 01/2021
1	Gonorrhea 01/2021
1	Hyperammonemia 12/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2020
1	Recurrent respiratory papillomatosis 01/2020
1	Parasitic Diseases (Parasitic Disease) 01/2020
1	Chronic Hepatitis C 01/2020

Drug/Important Bio-Agent (IBA)

78	VaccinesIBA 12/2022 - 01/2003
51	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 10/2003
35	DNA VaccinesIBA 12/2022 - 01/2003
31	AntigensIBA 03/2022 - 01/2002
16	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2002
14	A-Form DNA (A-DNA)IBA 11/2020 - 11/2006
10	AntibodiesIBA 01/2022 - 12/2005
10	Monoclonal AntibodiesIBA 01/2021 - 10/2013
7	Antiviral Agents (Antivirals)IBA 01/2020 - 03/2004
6	Hemagglutinins (Hemagglutinin)IBA 08/2020 - 07/2005
6	CytokinesIBA 01/2020 - 07/2005
6	Interleukin-15 (Interleukin 15)IBA 10/2009 - 07/2005
5	EpitopesIBA 06/2021 - 01/2011
4	reluscovtogene ralaplasmidIBA 12/2022 - 01/2020
4	EnzymesIBA 01/2022 - 09/2011
4	Neoplasm Antigens (Tumor Antigens)IBA 01/2021 - 01/2017
4	Nucleic AcidsIBA 06/2020 - 07/2015
4	Interleukin-33IBA 01/2019 - 03/2014
4	InterferonsIBA 01/2016 - 09/2008
4	Peptides (Polypeptides)IBA 01/2011 - 05/2006
4	vpr Gene ProductsIBA 02/2010 - 11/2006
3	VGX-3100IBA 01/2021 - 11/2015
3	Immunoglobulin G (IgG)IBA 01/2021 - 01/2017
3	Interleukin-12 (IL 12)IBA 06/2008 - 07/2005
2	NanovaccinesIBA 11/2020 - 04/2020
2	Protein Subunit VaccinesIBA 11/2020 - 05/2006
2	RNA (Ribonucleic Acid)IBA 06/2020 - 02/2012
2	Immune Checkpoint InhibitorsIBA 01/2019 - 01/2018
2	Glycoproteins (Glycoprotein)IBA 11/2018 - 05/2014
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2018 - 01/2018
2	3-phenyl-4,5-dihydro-5-isoxazole acetic acidIBA 03/2016 - 08/2014
2	Immunologic Adjuvants (Immunologic Adjuvant)IBA 08/2015 - 03/2014
2	Neutralizing AntibodiesIBA 07/2015 - 01/2015
2	HLA-DR Antigens (HLA-DR)IBA 01/2015 - 05/2012
2	AIDS VaccinesIBA 11/2012 - 07/2005
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 09/2011 - 03/2004
2	Caspase 9IBA 12/2002 - 10/2002
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Polysaccharides (Glycans)IBA 01/2022
1	Chewing Gum (Chewing Gums)IBA 01/2022
1	PerforinIBA 11/2021
1	NK Cell Lectin-Like Receptor Subfamily CIBA 11/2021
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 11/2021
1	COVID-19 VaccinesIBA 01/2021
1	Combined VaccinesIBA 01/2021
1	AmmoniaIBA 12/2020
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 12/2020
1	Thioacetamide (Thioacetamid)IBA 12/2020
1	ammonium acetateIBA 12/2020
1	Recombinant ProteinsIBA 11/2020
1	Imiquimod (Aldara)FDA LinkGeneric 09/2020
1	ArginaseIBA 09/2020
1	Broadly Neutralizing AntibodiesIBA 01/2020

Therapy/Procedure

29	Therapeutics 01/2021 - 10/2004
19	Immunotherapy 03/2022 - 10/2002
2	Organ Transplantation 01/2015 - 11/2012
1	Castration 01/2021
1	Blood Transfusion (Blood Transfusions) 01/2020